<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PAPER
  SYSTEM "paper-structure-annotation.dtd">
<PAPER><mode2 name="b312196h" hasDoc="yes" version="1153"/><TITLE><s sid="1"><CoreSc1 atype="GSC" type="Goa" conceptID="Goa1" novelty="None" advantage="None"/><text>Electrospray ionisation mass spectrometry analysis of differential turnover of phosphatidylcholine by human blood leukocytes<XREF TYPE="FOOTNOTE_MARKER" ID="fn1"/></text></s></TITLE><ABSTRACT><s sid="2"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac1" novelty="None" advantage="None"/><text>Synthesis and turnover of membrane phospholipids is essential for cell growth and function, and hydrolysis of membrane phospholipid is central to many intracellular signalling mechanisms.</text></s> <s sid="3"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/><text>Hydrolysis of phosphatidylcholine (PC) is a major signalling mechanism of neutrophils, leukocytes that phagocytose and kill bacteria as part of the innate immune response, generating phosphatidic acid, diacylglycerol and arachidonate-derived lipid second messengers.</text></s> <s sid="4"><CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="New" advantage="None"/><text>We describe here the application of tandem MS/MS electrospray ionisation mass spectrometry to the analysis of molecular patterns of PC synthesis by blood neutrophil and lymphocyte cells from healthy volunteers.</text></s> <s sid="5"><CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="New" advantage="None"/><text>This technique combined incorporation of the headgroup choline, methyl-labelled with deuterium (methyl-<IT>d</IT><SB>9</SB>-choline), with precursor scans of diagnostic labelled and native fragment ions.</text></s> <s sid="6"><CoreSc1 atype="GSC" type="Con" conceptID="Con1" novelty="None" advantage="None"/><text>The technique was very sensitive, permitting detection of <IT>d</IT><SB>9</SB> enrichment &lt;0.01%.</text></s> <s sid="7"><CoreSc1 atype="GSC" type="Con" conceptID="Con2" novelty="None" advantage="None"/><text>Results showed that the two different cell types maintained distinct molecular species compositions of PC, even though they were exposed to the same nutrient supply in blood.</text></s> <s sid="8"><CoreSc1 atype="GSC" type="Con" conceptID="Con3" novelty="None" advantage="None"/><text>Moreover, while the pattern of lymphocyte PC synthesis directly mirrored composition, the fractional synthesis of arachidonoyl (C20∶4,n-6)-containing PC species in neutrophils was greatly enhanced compared with composition.</text></s> <s sid="9"><CoreSc1 atype="GSC" type="Con" conceptID="Con4" novelty="None" advantage="None"/><text>This increased turnover of arachidonoyl species in neutrophils may be related to the active synthesis of eicosanoids and other arachidonoyl-derived mediators in this cell type.</text></s></ABSTRACT><BODY><DIV DEPTH="1"><HEADER>Introduction</HEADER><P><s sid="10"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac3" novelty="None" advantage="None"/><text>Enzymatic pathways for synthesis and turnover of membrane phospholipids are well characterised, but mechanisms regulating their molecular specificity remain unclear.</text></s> <s sid="11"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac4" novelty="None" advantage="None"/><text>The combinations of fatty acyl moieties esterified to the glycerol backbone define the molecular species composition of glycerophospholipids and are major determinants of their biological functions in membranes.</text></s> <s sid="12"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac5" novelty="None" advantage="None"/><text>These functions include providing the physico–chemical environment for optimal membrane protein function and acting as substrates for a wide range of intracellular signalling phospholipases.<REF TYPE="P" ID="cit1 cit2 cit3">1–3</REF></text></s> <s sid="13"><CoreSc1 atype="GSC" type="Met" conceptID="Met2" novelty="Old" advantage="None"/><text>Traditional analysis of total esterified fatty acids in such lipids by gas chromatography provides little information about such specificities of phospholipid structure and function.</text></s> <s sid="14"><CoreSc1 atype="GSC" type="Met" conceptID="Met3" novelty="Old" advantage="None"/><text>In contrast, the application of electrospray ionisation mass spectrometry (ESI-MS) has had a dramatic impact on studies characterising membrane lipid compositions, due to its exquisite sensitivity and the detailed nature of the information provided.<REF TYPE="P" ID="cit4 cit5">4,5</REF></text></s> <s sid="15"><CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="New" advantage="None"/><text>In this paper, we describe the further application of ESI-MS/MS to quantify absolute rates of phosphatidylcholine (PC) synthesis in intact human white blood cells.</text></s></P><P><s sid="16"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac6" novelty="None" advantage="None"/><text>Studies of PC synthesis by livers<REF TYPE="P" ID="cit6 cit7">6,7</REF> and lungs<REF TYPE="P" ID="cit8">8</REF> of experimental animals, using HPLC to follow incorporations of radioactive substrates, have shown that newly synthesised PC is acyl remodelled to its final membrane composition by sequential actions of phospholipases and acyltransferase enzymes.</text></s> <s sid="17"><CoreSc1 atype="GSC" type="Mot" conceptID="Mot1" novelty="None" advantage="None"/><text>Little is known about the operation of comparable synthetic mechanisms in other tissues and cell type, especially from human subjects.</text></s> <s sid="18"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac7" novelty="None" advantage="None"/><text>We have previously used ESI-MS/MS to document the incorporation of (methyl-<IT>d</IT><SB>9</SB>-choline) into endonuclear PC of cultured cancer cell lines,<REF TYPE="P" ID="cit9">9</REF> but this provides no insight into the relative synthetic rates of quiescent primary human cell types.</text></s> <s sid="19"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac8" novelty="None" advantage="None"/><text>White blood cells represent a readily accessible population of primary human cells, and sub-population of lymphocyte and neutrophils cells can be obtained in reasonable yield.</text></s> <s sid="20"><CoreSc1 atype="GSC" type="Mot" conceptID="Mot2" novelty="None" advantage="None"/><text>This ability is important, as these two cell types have very different functions <IT>in vivo</IT>.</text></s> <s sid="21"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac9" novelty="None" advantage="None"/><text>Lymphocytes orchestrate the humoral immune response, while neutrophils are central to the immediate innate host defence responses to microbial pathogens.</text></s> <s sid="22"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac10" novelty="None" advantage="None"/><text>Hydrolysis of PC by phospholipase D is a major mechanism regulating the activation of neutrophils NADPH oxidase,<REF TYPE="P" ID="cit10">10</REF> the enzyme complex responsible for generation of bacteriocidal oxygen radicals, and maintenance of an optimal PC composition is thought to be central to this process.</text></s> <s sid="23"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac11" novelty="None" advantage="None"/><text>In addition, neutrophils are major sources for the generation of prostaglandins and leukotrienes derived from arachidonic acid (C20∶4,n-6),<REF TYPE="P" ID="cit11">11</REF> which in turn is released from membrane phospholipids by phospholipase A<SB>2</SB> activity.</text></s> <s sid="24"><CoreSc1 atype="GSC" type="Goa" conceptID="Goa2" novelty="None" advantage="None"/><text>Consequently, this study provided an opportunity to compare mechanisms of PC synthesis by two cell types derived from the same environment which can then be linked with biological function.</text></s></P></DIV><DIV DEPTH="1"><HEADER>Experimental</HEADER><DIV DEPTH="2"><HEADER>Incubation of blood cells with deuteriated choline</HEADER><P><s sid="25"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp1" novelty="None" advantage="None"/><text>Venous blood samples (10 ml) were taken from healthy volunteers using lithium heparin as anti-coagulant, in accordance with permission from the Local Research Ethics Committee.</text></s> <s sid="26"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp2" novelty="None" advantage="None"/><text>Whole blood was diluted 1∶1 (v/v) with phosphate buffered saline (PBS) and incubated with deuteriated choline (methyl-<IT>d</IT><SB>9</SB>-choline, 100 µg ml<SP>–1</SP>) (Pointe-Claire, Quebec, Canada) for 3 h at 37 °C in an atmosphere of 5% (v/v) CO<SB>2</SB>.</text></s> <s sid="27"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp3" novelty="None" advantage="None"/><text>Lymphocyte and neutrophil cell fractions were prepared from diluted blood (8 ml) by sequential centrifugation steps initially over 4 ml of polymorphprep (Robbins Scientific, Solihull, UK) and then over lymphozyten separation medium (PAA laboratories, Yeovil, UK).</text></s> <s sid="28"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp4" novelty="None" advantage="None"/><text>Purified cell populations were suspended finally at 2 × 10<SP>7</SP> cells ml<SP>–1</SP> in PBS.</text></s> <s sid="29"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp5" novelty="None" advantage="None"/><text>Cells from 1 ml of each fraction were centrifuged at 13 000 rpm in a microcentrifuge (Sanyo MSE Micro Centaur) for 5 s, resuspended in 100 µl PBS and fixed in 900 µl of ice-cold methanol.</text></s></P></DIV><DIV DEPTH="2"><HEADER>Phospholipid purification</HEADER><P><s sid="30"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp6" novelty="None" advantage="None"/><text>Dimyristoyl-phosphatidylcholine (PC 14∶0/14∶0; 15 nmol/10<SP>7</SP> cells) dissolved in 50 µl chloroform was added before extraction as an internal recovery standard.</text></s> <s sid="31"><CoreSc1 atype="GSC" type="Met" conceptID="Met4" novelty="Old" advantage="None"/><text>Phospholipids from cell fractions were extracted with acidified chloroform and methanol.<REF TYPE="P" ID="cit12">12</REF></text></s> <s sid="32"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp7" novelty="None" advantage="None"/><text>The PC fraction was then purified from the chloroform phase on 100 mg BondElut aminopropyl solid phase extraction cartridges (Phenomenex, Macclesfield, UK) and finally dissolved in methanol∶chloroform∶water∶NH<SB>4</SB>OH (7∶2∶0.2∶0.2, v∶v) at a concentration of 1 µM.</text></s></P></DIV><DIV DEPTH="2"><HEADER>Mass spectrometry</HEADER><P><s sid="33"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/><text>ESI-MS was performed on a Micromass Quatro Ultima triple quadrupole mass spectrometer (Micromass, Wythenshaw, UK) equipped with an electrospray ionisation interface.</text></s> <s sid="34"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>PC samples were introduced to the mass spectrometer by direct injection at a flow rate of 5 µl min<SP>–1</SP>, and cumulative spectra were obtained for 10 scans each of 12 s.</text></s> <s sid="35"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs1" novelty="None" advantage="None"/><text>Capillary voltage was set at +3.5 keV and cone voltage at 100 V. Following collision-induced fragmentation with argon gas, endogenous PC molecules produced a diagnostic fragment with <IT>m</IT>/<IT>z</IT> = +184, corresponding to the protonated phosphocholine headgroup.</text></s> <s sid="36"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs2" novelty="None" advantage="None"/><text>Newly synthesised PC, which contained 9 deuterons, produced an analogous fragment at <IT>m</IT>/<IT>z</IT> = +193.</text></s> <s sid="37"><CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="New" advantage="None"/><text>Sequential precursor scans of the <IT>m</IT>/<IT>z</IT> 184 and 193 moieties permitted the determination of endogenous and newly synthesised PC species.<REF TYPE="P" ID="cit9 cit13">9,13</REF></text></s> <s sid="38"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp10" novelty="None" advantage="None"/><text>Mass spectra were quantified after conversion to centroid format and export to an Excel spreadsheet.</text></s> <s sid="39"><CoreSc1 atype="GSC" type="Mod" conceptID="Mod1" novelty="None" advantage="None"/><text>Ion intensities for selected species were corrected first for the <SP>13</SP>C isotope effect and second for the decreasing efficiency of MS/MS fragmentation with increasing molecular mass.</text></s> <s sid="40"><CoreSc1 atype="GSC" type="Mod" conceptID="Mod2" novelty="None" advantage="None"/><text>Because of the approximately 1% natural abundance of <SP>13</SP>C in biological compounds, all PC species were detected as a series of ion peaks of increasing unit mass and decreasing intensity.</text></s> <s sid="41"><CoreSc1 atype="GSC" type="Mod" conceptID="Mod3" novelty="None" advantage="None"/><text>The fractional abundance of the [M + H]<SP>+</SP> molecular ion therefore decreased with increasing molecular mass, and [M + 2H]<SP>+</SP> ions overlapped with PC species two mass units higher.</text></s> <s sid="42"><CoreSc1 atype="GSC" type="Mod" conceptID="Mod4" novelty="None" advantage="None"/><text>For each individual PC species, correction for these effects was achieved by subtracting the calculated [M + 2H]<SP>+</SP> ion intensity of the preceding PC species and then dividing by the fractional [M + H]<SP>+</SP> ion intensity calculated as a proportion of all ion peaks.</text></s> <s sid="43"><CoreSc1 atype="GSC" type="Mod" conceptID="Mod5" novelty="None" advantage="None"/><text>The formula for reduced response factor with increasing <IT>m</IT>/<IT>z</IT> was calculated experimentally as follows: <IT>a</IT> = 2 × 10<SP>13</SP><IT>b</IT><SP>–3.9873</SP>, where <IT>a</IT> = reduced response factor relative to a value of 1.00 for PC14∶0/14∶0 and <IT>b</IT> = <IT>m</IT>/<IT>z</IT> value.</text></s> <s sid="44"><CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="New" advantage="None"/><text>Identities of the major PC molecular species in each ion peak were established from fragmentation patterns of [M-15]<SP>–</SP> in negative ionisation, which represents loss of one methyl group from the molecular ion.</text></s> <s sid="45"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac12" novelty="None" advantage="None"/><text>This was feasible as the BondElut sample purification removed any phosphatidylethanolamine and acidic phospholipid that would have interfered with such analysis in the total lipid extract under conditions of negative ionisation.</text></s> <s sid="46"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs3" novelty="None" advantage="None"/><text>Product ions due to fatty acyl substitutes were major components of these fragmentation spectra and provided a direct assessment of their combinations for each PC species.</text></s> <s sid="47"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs3" novelty="None" advantage="None"/><text>The relative intensities of each product fatty acid also enabled their assignment to either the <IT>sn</IT>-1 or <IT>sn</IT>-2 positions.<REF TYPE="P" ID="cit14">14</REF></text></s> <s sid="48"><CoreSc1 atype="GSC" type="Res" conceptID="Res1" novelty="None" advantage="None"/><text>Consequently, the molecular species of PC identified in this paper represent in each case the major component in each respective ion peak.</text></s> <s sid="49"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs4" novelty="None" advantage="None"/><text>The majority of PC molecules detected were diacyl species where both fatty acyl moeties are esterified to the glycerol backbone of the molecule.</text></s> <s sid="50"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs5" novelty="None" advantage="None"/><text>A minor population of <IT>sn</IT>-1-alkyl-2-acyl PC (plasmanyl) species was also detected and characterised by exhibiting molecular ions 14 <IT>m</IT>/<IT>z</IT> units lower than the corresponding diacyl species combined with fragmentation in negative ionisation to produce solely the acyl group from the <IT>sn</IT>-2 position.</text></s> <s sid="51"><CoreSc1 atype="GSC" type="Res" conceptID="Res2" novelty="None" advantage="None"/><text>The resistance of these ether PC species to acid eliminated the possibility that they were <IT>sn</IT>-1-alkenyl-2-acyl species, as the vinyl bond in such plasmenyl molecules is acid labile<REF TYPE="P" ID="cit14">14</REF>.</text></s></P></DIV></DIV><DIV DEPTH="1"><HEADER>Results and discussion</HEADER><P><s sid="52"><CoreSc1 atype="GSC" type="Mod" conceptID="Mod6" novelty="None" advantage="None"/><text>Due to the quaternary nitrogen in the choline headgroup, PC species are readily detected by ESI-MS in positive ionisation and, as PC ions carry only a single charge, mass∶charge (<IT>m</IT>/<IT>z</IT>) is equivalent to molecular mass.</text></s> <s sid="53"><CoreSc1 atype="GSC" type="Mod" conceptID="Mod6" novelty="None" advantage="None"/><text>Any methyl-<IT>d</IT><SB>9</SB>-choline incorporated during PC synthesis will produce an ion peak 9 <IT>m</IT>/<IT>z</IT> units higher than the corresponding endogenous PC species.</text></s> <s sid="54"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs6" novelty="None" advantage="None"/><text>However, given the relatively low rate of incorporation of label over the three hour incubation, it was not possible to distinguish any incorporated material in the full positive scan from background endogenous material (Fig. 1A).</text></s> <s sid="55"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs6" novelty="None" advantage="None"/><text>This figure illustrates a portion of the spectrum with PC16∶0/18∶1 (<IT>m</IT>/<IT>z</IT> 760) as the predominant PC species present, and clearly demonstrates that any newly-synthesised PC16∶0/18∶1, expected at <IT>m</IT>/<IT>z</IT> 769, could not be resolved from minor ion peaks derived from endogenous PC species.</text></s> <s sid="56"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs7" novelty="None" advantage="None"/><text>Fragmentation of the ion at <IT>m</IT>/<IT>z</IT> 769 in positive ionisation generated a major diagnostic product at <IT>m</IT>/<IT>z</IT> 184, corresponding to the phosphocholine headgroup, together with a less abundant but well resolved ion at <IT>m</IT>/<IT>z</IT> 193 derived from PC containing incorporated methyl-<IT>d</IT><SB>9</SB>-choline (Fig. 1B, upper panel).</text></s> <s sid="57"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs8" novelty="None" advantage="None"/><text>Comparable fragmentation of the ion at <IT>m</IT>/<IT>z</IT> 760 produced only the single product at <IT>m</IT>/<IT>z</IT> 184 (Fig. 1B, lower panel).</text></s> <s sid="58"><CoreSc1 atype="GSC" type="Res" conceptID="Res3" novelty="None" advantage="None"/><text>This result indicates that while <IT>m</IT>/<IT>z</IT> 760 was comprised solely of endogenous PC, the ion at <IT>m</IT>/<IT>z</IT> 193 contained both endogenous and a smaller amount of newly-synthesised PC.</text></s> <s sid="59"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs9" novelty="None" advantage="None"/><text>The ability to distinguish these product ions formed the basis of the technique for quantifying PC synthesis by comparing ion counts of precursor scans of <IT>m</IT>/<IT>z</IT> 193 with those of comparable precursor scans of <IT>m</IT>/<IT>z</IT> 184 (Fig. 1C).</text></s> <s sid="60"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs10" novelty="None" advantage="None"/><text>The upper panel of Fig. 1C represents newly synthesised PC species that fragmented to give phosphoryl-(methyl-<IT>d</IT><SB>9</SB>)-choline (<IT>m</IT>/<IT>z</IT> 193) while the lower panel indicates endogenous PC species that generated solely the <IT>m</IT>/<IT>z</IT> 184 fragment ion.</text></s> <s sid="61"><CoreSc1 atype="GSC" type="Res" conceptID="Res4" novelty="None" advantage="None"/><text>Although <IT>d</IT><SB>9</SB>-enriched material was only a minor product of the ion peak at <IT>m</IT>/<IT>z</IT> 769, the pattern of PC species with incorporated methyl-<IT>d</IT><SB>9</SB>-choline was clearly distinguishable from the endogenous material.</text></s> <s sid="62"><CoreSc1 atype="GSC" type="Res" conceptID="Res5" novelty="None" advantage="None"/><text>Intensities of these two spectra are normalised to the major ion peak displayed in each case as the total ion count for the precursor scan of <IT>m</IT>/<IT>z</IT> 193 was less than 1% that of <IT>m</IT>/<IT>z</IT> 184 and would consequently be negligible if displayed on the same scale.</text></s> <s sid="63"><CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="New" advantage="None"/><text>Enrichment of PC with methyl-<IT>d</IT><SB>9</SB>-choline was calculated from the ratio of the sums of the corrected ion counts of identified species in precursor scans of <IT>m</IT>/<IT>z</IT> 193 compared with <IT>m</IT>/<IT>z</IT> 184.</text></s> <s sid="64"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac13" novelty="None" advantage="None"/><text>This enrichment is a reasonable estimate of the absolute rate of PC synthesis in these cells, as methyl-<IT>d</IT><SB>9</SB>-choline was added to the medium in at least a ten-fold excess over unlabelled choline in the cells.</text></s></P><P><s sid="65"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs11" novelty="None" advantage="None"/><text>Comparison of typical PC spectra, determined as precursor scans of <IT>m</IT>/<IT>z</IT> 184, demonstrate considerable differences between purified lymphocyte and neutrophil preparations (Fig. 2).</text></s> <s sid="66"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs11" novelty="None" advantage="None"/><text>While monounsaturated species were the major components for both cell types (PC16∶0/18∶1, <IT>m</IT>/<IT>z</IT> 760), lymphocyte PC was enriched in species containing arachidonate (PC16∶0/20∶4, <IT>m</IT>/<IT>z</IT> 782; PC18∶1/20∶4, <IT>m</IT>/<IT>z</IT> 808; PC18∶0/20∶4, <IT>m</IT>/<IT>z</IT> 810) and, paradoxically, in the disaturated species PC16∶0/16∶0 (<IT>m</IT>/<IT>z</IT> 734) (Fig. 2A).</text></s> <s sid="67"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs12" novelty="None" advantage="None"/><text>By comparison, neutrophil PC was relatively depleted in arachidonoyl-containing species but contained increased amounts of 1-alkyl-2-acyl species characterised by an ether rather than an ester bond at the <IT>sn</IT>-1 position (<IT>e.g.</IT> PC16∶0alk/18∶1, <IT>m</IT>/<IT>z</IT> 746) (Fig. 2B).</text></s></P><P><s sid="68"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs13" novelty="None" advantage="None"/><text>Comparable analyses of PC synthesis from precursor scans of <IT>m</IT>/<IT>z</IT> 193 are illustrated in Fig. 3.</text></s> <s sid="69"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs14" novelty="None" advantage="None"/><text>Fractional PC synthesis rates over the experimental period were 1.49 ± 0.16% for lymphocytes and 0.59 ± 0.21% for neutrophils (mean ± sd, <IT>n</IT> = 5).</text></s> <s sid="70"><CoreSc1 atype="GSC" type="Res" conceptID="Res6" novelty="None" advantage="None"/><text>Despite this low abundance compared with endogenous material, the spectra in Fig. 3 demonstrate clearly the ready quantification of such scans, with typical signal∶noise ratios &gt; 200.</text></s> <s sid="71"><CoreSc1 atype="GSC" type="Res" conceptID="Res7" novelty="None" advantage="None"/><text>Comparison of these spectra suggest low rates of incorporation of methyl-<IT>d</IT><SB>9</SB>-choline into the 1-alkyl-2-acyl plasmanylcholine in both lymphocytes (Fig. 3A) and neutrophils (Fig. 3B), but synthesis of all other PC species was well resolved at 9 <IT>m</IT>/<IT>z</IT> units higher.</text></s></P><P><s sid="72"><CoreSc1 atype="GSC" type="Res" conceptID="Res8" novelty="None" advantage="None"/><text>Analysis of the combined data suggested that negligible fatty acyl remodelling mechanisms operated in PC synthesis by human blood lymphocytes (Fig. 4A), as the pattern of methyl-<IT>d</IT><SB>9</SB>-choline was essentially the same as that of endogenous PC.</text></s> <s sid="73"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs15" novelty="None" advantage="None"/><text>For neutrophils by comparison, the fractional incorporation of methyl-<IT>d</IT><SB>9</SB>-choline into arachidonoyl species of PC (especially PC18∶0/20∶4) was considerably greater than the relative abundance of the endogenous molecular species (Fig. 4B).</text></s> <s sid="74"><CoreSc1 atype="GSC" type="Con" conceptID="Con4" novelty="None" advantage="None"/><text>The simplest interpretation of this observation is a rapid turnover rate of the arachidonoyl moiety in neutrophils PC.</text></s> <s sid="75"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac14" novelty="None" advantage="None"/><text>This in turn may be related to the high metabolic requirement in neutrophils for arachidonate, generated by the action of phospholipase A<SB>2</SB> on membrane phospholipid,<REF TYPE="P" ID="cit15">15</REF> for generation of eicosanoid inflammatory mediators, especially leukotriene B<SB>4</SB>.</text></s> <s sid="76"><CoreSc1 atype="GSC" type="Con" conceptID="Con5" novelty="None" advantage="None"/><text>The mechanisms responsible for this increased turnover of arachidonate in neutrophil PC require further investigation, but the results of this study provide a good illustration how the application of a physical technique such as ESI-MS can provide considerably greater detail and sensitivity of information than previous approaches following the incorporations of radiolabelled precursors.</text></s> <s sid="77"><CoreSc1 atype="GSC" type="Con" conceptID="Con6" novelty="None" advantage="None"/><text>Moreover, they also demonstrate that previous concepts of acyl remodelling in PC synthesis, derived from studies in liver and lungs,<REF TYPE="P" ID="cit6 cit7 cit8">6–8</REF> are not applicable to human blood leukocytes.</text></s> <s sid="78"><CoreSc1 atype="GSC" type="Con" conceptID="Con7" novelty="None" advantage="None"/><text>These studies suggested that PC was synthesised in both tissues enriched in diunsaturated species, predominately PC16∶0/18∶2, and was remodelled by subsequent actions of phospholipases and acyltransferases to, respectively, polyunsaturated or disaturated species.</text></s> <s sid="79"><CoreSc1 atype="GSC" type="Con" conceptID="Con8" novelty="None" advantage="None"/><text>As both liver and lungs are organs characterised by secretion of phospholipid, as lipoprotein or lung surfactant, it is possible that this pattern of acyl remodelling is characteristic of PC destined for secretion rather than for structural membrane synthesis.</text></s></P></DIV></BODY></PAPER>